Protease inhibitors: Synthesis of a series of bacterial collagenase inhibitors of the sulfonyl amino acyl hydroxamate type

Journal of Medicinal Chemistry

Volumn 44, Issue 13, 2001, Pages 2253-2258

  Clare, B W ^a   Scozzafava, A ^b   Supuran, C T ^b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE DERIVATIVE; BACTERIAL ENZYME; COLLAGENASE INHIBITOR; HYDROXAMIC ACID DERIVATIVE; PROTEINASE INHIBITOR;

ARTICLE; CLOSTRIDIUM HISTOLYTICUM; DRUG SYNTHESIS; ENZYME INHIBITION; INHIBITION KINETICS; NONHUMAN; STRUCTURE ACTIVITY RELATION;

HYDROXAMIC ACIDS; INDICATORS AND REAGENTS; MAGNETIC RESONANCE SPECTROSCOPY; MICROBIAL COLLAGENASE; PROTEASE INHIBITORS; SPECTROPHOTOMETRY, INFRARED; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; STRUCTURE-ACTIVITY RELATIONSHIP; SULFONES;

EID: 0035927438     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm010087e     Document Type: Article

References (46)

1. Protease inhibitors: Current status and future prospects
2. Structural and biochemical studies of retroviral proteases
3. Bacterial proteinases as targets for the development of second generation antibiotics
4. Bacterial proteases: Current therapeutic use and future prospects for the development of new antibiotics
5. Bacterial metalloproteases as the toxic factor in infection
6. Design and therapeutic application of matrix metalloproteinase inhibitors
7. Matrix metalloproteinase inhibitors in arthritis
8. Molecular recognition of protein-ligand complexes: Applications to drug design
9. Matrix metalloproteinase inhibitors
10. Matrix metalloproteinases
11. Vertebrate collagenases
12. Human neutrophil collagenase
13. Matrix metalloproteinases
14. Treatment of osteoporosis with MMP inhibitors
15. Matrix metalloproteinases and their inhibitors in tumor growth and invasion
16. Structure determination and analysis of human neutrophil collagenase complexed with a hydroxamate inhibitor
17. X-ray structures of human neutrophil collagenase complexed with hydroxamate and peptide thiols inhibitors. Implications for substrate binding and rational drug design
18. Design and synthesis of malonic acid-based inhibitors of human neutrophil collagenase (MMP-8)
19. Sulfonamide-based hydroxamic acids as potent inhibitors of mouse macrophage metalloelastase
20. Hydroxamate derivatives of substrate analogous peptides containing aminomalonic acid are potent inhibitors of matrix metalloproteinases
21. Purification and separation of individual collagenases of Clostridium histolyticum using red dye ligand chromatography
22. Characterization of the individual coilagenases from Clostridium histolyticum
23. Clostridium collagenases
24. Evolutionary families of metallopeptidases
25. Virulence genes of Clostridium perfringens
26. A study of the collagen-binding domain of a 116kDa Clostridium histolyticum collagenase
27. Gene duplication and multiplicity of collagenase in Clostridium histolyticum
28. Identification of metal ligands in the Clostridium histolyticum ColH collagenase
29. Protease inhibitors. Part 5. Alkyl/arylsulfonyl- and arylsulfonylureido-/arylureido- glycine hydroxamate inhibitors of Clostridium histolyticum collagenase
30. Protease inhibitors. Part 7. Inhibition of Clostridium histolyticum collagenase with sulfonylated derivatives of L-valine hydroxamate
31. Protease inhibitors. Part 8. Synthesis of potent Clostridium histolyticum collagenase inhibitors incorporating sulfonylated L-alanine hydroxamate moieties
32. Protease inhibitors. Synthesis of Clostridium histolyticum collagenase inhibitors incorporating sulfonyl-L-alanine hydroxamate moieties
33. Protease inhibitors: Synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties
34. Discovery of CGS 27023A, a nonpeptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits
35. 2 pockets of matrix metalloproteinases. A niche for potent acyclic sulfonamide inhibitors
36. Design, synthesis and biological evaluation of potent thiazine and thiazepine-based matrix metalloproteinase inhibitors
37. Homology modeling of gelatinase catalytic domains and docking simulations of novel sulfonamide inhibitors
38. Carbonic anhydrase inhibitors: Synthesis of water-soluble, topically effective intraocular pressure lowering aromatic/heterocyclic sulfonamides containing cationic or anionic moieties: Is the tail more important than the ring?
39. Carbonic anhydrase inhibitors: Synthesis of water-soluble, amino acyl/dipeptidyl sulfonamides possessing long-lasting intraocular pressure-lowering properties via the topical route
40. Carbonic anhydrase inhibitors: Synthesis of water-soluble, topically effective intraocular pressure lowering aromatic/heterocyclic sulfonamides containing 8-quinoline-sulfonyl moieties: Is the tail more important than the ring?
41. Carbonic anhydrase inhibitors. Part 71. Synthesis and ocular pharmacology of a new class of watersoluble, topically effective intraocular pressure lowering sulfonamides incorporating picolinoyl moieties
42. Carbonic anhydrase inhibitors. Part 70. Synthesis and ocular pharmacology of a new class of water-soluble, topically effective intraocular pressure lowering agents derived from nicotinic acid and aromatic/heterocyclic sulfonamides
43. Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives
44. Carbonic anhydrase inhibitors. Arylsulfonylureido and arylureido- substituted aromatic and heterocyclic sulfonamides: Toward selective inhibitors of carbonic anhydrase isozyme I
45. A continuous spectrophotometric assay for Clostridium histolyticum collagenase